Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study



: Pär Stattin, Andrew J. Vickers, Daniel D. Sjoberg, Robert Johansson, Torvald Granfors, Mattias Johansson, Kim Pettersson, Peter T. Scardino, Göran Hallmans, Hans Lilja

Publisher: ELSEVIER SCIENCE BV

: 2015

: European Urology

: EUROPEAN UROLOGY

: EUR UROL

: 68

: 2

: 207

: 213

: 7

: 0302-2838

DOI: https://doi.org/10.1016/j.eururo.2015.01.009


Patient summary: For men in their fifties, screening should focus on those in the top 10% to 25% of PSA values because the majority of subsequent cases of distant metastasis are found among these men. Testing of four kallikrein markers in men with an elevated PSA could aid biopsy decision making. (C) 2015 European Association of Urology. Published by Elsevier B.V.




Last updated on 2024-26-11 at 18:51